🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.810
+0.130 (7.74%)
At close: Nov 20, 2026, 4:00 PM EST
1.870
+0.060 (3.31%)
After-hours: Nov 20, 2026, 7:59 PM EST

Pyxis Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11.0413.8616.15---
Revenue Growth
291.42%-14.17%----
Cost of Revenue
2.392.390.48---
Gross Profit
8.6511.4715.67---
Selling, General & Admin
21.819.6222.4930.8337.3518.66
Research & Development
74.3173.758.7549.5986.1351.05
Operating Expenses
96.1193.3281.2480.42123.4869.72
Operating Income
-87.46-81.85-65.57-80.42-123.48-69.72
Interest & Investment Income
1.853.617.046.632.760.02
Earnings From Equity Investments
------0.23
Other Non Operating Income (Expenses)
------6.05
EBT Excluding Unusual Items
-85.61-78.24-58.53-73.79-120.72-75.98
Pretax Income
-85.61-78.24-79.5-73.79-120.72-75.98
Income Tax Expense
1.11.39-2.16---
Net Income
-86.71-79.62-77.33-73.79-120.72-75.98
Net Income to Common
-86.71-79.62-77.33-73.79-120.72-75.98
Net Income Growth
------
Shares Outstanding (Basic)
68625840338
Shares Outstanding (Diluted)
68625840338
Shares Change
10.81%6.33%46.46%20.80%288.93%724.14%
EPS (Basic)
-1.27-1.28-1.32-1.85-3.65-8.95
EPS (Diluted)
-1.27-1.28-1.32-1.85-3.65-8.95
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-70.93-63.51-57.91-77.44-95.73-35.87
Free Cash Flow Per Share
-1.04-1.02-0.99-1.94-2.90-4.22
Gross Margin
78.37%82.77%97.06%---
Operating Margin
-792.32%-590.60%-406.11%---
Profit Margin
-785.54%-574.55%-478.95%---
Free Cash Flow Margin
-642.57%-458.30%-358.66%---
EBITDA
-83.5-77.33-62.59-78.49-122.77-69.07
D&A For EBITDA
3.964.512.981.930.710.65
EBIT
-87.46-81.85-65.57-80.42-123.48-69.72
Revenue as Reported
13.8613.8616.15---
SEC Filings: 10-K · 10-Q